HOME >> BIOLOGY >> NEWS
News tips from The Journal of Neuroscience

1. Wiring up for Color
Patricia R. Jusuf, Paul R. Martin, and Ulrike Grnert

The primate midget-parvocellular (PC) visual system contributes to redgreen color detection. In this week's Journal, Jusuf et al. sought to determine whether selective wiring of the pathway connects redgreen-sensitive cells with one another. The PC pathway successively involves cone photoreceptors, midget bipolar cells, midget ganglion cells, PC relay cells in the lateral geniculate nucleus, and finally the visual cortex. To determine whether color selectivity arises from cone-selective contacts, the authors examined the OFF pathway of the peripheral retina in dichromatic (redgreen color blind) and trichromatic (color normal) marmosets. They identified OFF midget bipolar cells immunohistochemically and retrogradely labeled OFF midget ganglion cells. The authors found a loose convergence pattern of connections between these populations that was not related to redgreen color vision. Thus, the function of the PC pathway in the peripheral retina does not depend on recognition between individual members of bipolarganglion cell mosaics.

2. BDNF and Thermostatic Control
Adi Katz and Noam Meiri

We generally take our internal body thermostat for granted, but this week, Katz and Meiri provide evidence that this system is sensitive to early experience. The authors examined the developmental plasticity of this hypothalamic controller during the critical period. In the chick, heat- and cold-sensitive neurons are located in the preoptic/anterior hypothalamus (PO/AH). The authors report that brain-derived neurotrophic factor (BDNF) is a key regulator in the PO/AH. Chicks that were heat-conditioned (37.5C for 24 h) on postnatal day 3 had increases in BDNF but not nerve growth factor or neurotrophin-3. Cold conditioning also induced BDNF transcription, whereas cold acclimation in older chicks did not. Both heat- and cold-induced BDNF expression was lim
'"/>

Contact: Sara Harris
sharris@sfn.org
202-962-4000
Society for Neuroscience
11-Apr-2006


Page: 1 2 3

Related biology news :

1. News tips from the Journal of Neuroscience
2. News tips from the Journal of Neuroscience
3. News tips from the Journal of Neuroscience
4. News tips from the Journal of Neuroscience
5. Tips from the Journals of the American Society for Microbiology
6. Journalists can register now for ECCO 14 -- the European Cancer Conference
7. Journal of Alzheimers Disease achieves significant impact factor
8. News tips from the Journal of Neuroscience
9. Highlights from the July 2007 Journal of the American Dietetic Association
10. News tips from the Journal of Neuroscience
11. Journal of Nuclear Medicines impact grows, remains consistently high over past 5 years

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: News tips from The Journal Neuroscience

(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/28/2015)... -- According to a new market research ... Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem Cells, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 2,150.48 Million in 2015, ... 2020. Browse 74 Tables and 95 ...
(Date:8/28/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, ... June 30, 2015, corporate highlights, and near-term milestones.  ... available at www.sedar.com ,  www.edgar.com ... "RepliCel expects to launch its RCS-01 treatment for ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... venture capital funds, investment firms and animal health companies to hear from animal ... $160 million. Several have also received licensing agreements or distribution contracts. This ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
Cached News: